Schwarz Pharma
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- NOTIS 20 gastro-resistant capsule, hard 20 mg
- B01 - Agentes antitrombóticos
- TICLO film-coated tablet 250 mg
- C01 - Terapia cardíaca
- EFFOX coated tablet 10 mg
- EFFOX coated tablet 20 mg
- EFFOX coated tablet 40 mg
- EFFOX LONG prolonged-release tablet 50 mg
- EFFOX LONG prolonged-release tablet 75 mg
- ISOKET concentrate for solution for infusion 10 mg/10 ml
- ISOKET oromucosal spray 1.25 mg/dose
- ISOKET prolonged-release capsule, hard 120 mg
- ISOKET prolonged-release tablet 20 mg
- ISOKET prolonged-release tablet 40 mg
- ISOKET tablet 5 mg
- PERLINGANIT concentrate for solution for infusion 10 mg/10 ml
- PERLINGANIT concentrate for solution for infusion 50 mg/50 ml
- PROSTAVASIN powder for solution for infusion 20 µg
- PROSTAVASIN powder for solution for infusion 60 µg
- C02 - Antihipertensivos
- PROSTATIC tablet 1 mg
- PROSTATIC tablet 2 mg
- PROSTATIC tablet 4 mg
- C05 - Vasoprotectores
- OTREX tablet 600 mg
- C07 - Betabloqueantes
- ABUTOL film-coated tablet 200 mg
- ABUTOL LONG prolonged-release tablet 400 mg
- C08 - Bloqueantes del canal de calcio
- OXYCARDIL coated tablet 60 mg
- OXYCARDIL prolonged-release tablet 120 mg
- OXYCARDIL prolonged-release tablet 180 mg
- OXYCARDIL prolonged-release tablet 240 mg
- C09 - Agentes activos sobre el sistema renina-angiotensina
- CARDIOTENSIN coated tablet 15 mg
- CARDIOTENSIN coated tablet 7.5 mg
- C10 - Agentes modificadores de los lípidos
- CARDIN film-coated tablet 10 mg
- CARDIN film-coated tablet 20 mg
- CARDIN film-coated tablet 40 mg
- PRAVACHOL tablet 20 mg
- N04 - Antiparkinsonianos
- NEUPRO transdermal patch 2 mg/24 h
- NEUPRO transdermal patch 4 mg/24 h
- NEUPRO transdermal patch 6 mg/24 h
- NEUPRO transdermal patch 8 mg/24 h